Evidence map›Paper›PMID 9250144›Full record

ReviewThe American journal of pathology1997

Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation.

R S Smith, T J Smith, T M Blieden, R P Phipps

Abstract readReview
In one paragraph

Review in The American journal of pathology, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 184 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
184citing papers in PubMed, 1 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

184 citing papers in PubMed, 1 synthesis or guideline pooled it, 515 citations in OpenAlex.

  1. Tocilizumab for thyroid eye disease.The Cochrane database of systematic reviews · 2018
    Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Cardiac fibroblasts in heart failure and regeneration.Frontiers in cell and developmental biology · 2024
    Review
  19. Review
  20. Article

124 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

R S SmithDepartment of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, New York, USA.
T J Smith
T M Blieden
R P Phipps
University of Rochester · US

Funding

REGULATION OF IMMUNITY BY PROSTAGLANDINSR01DE011390 · NIDCR · UNIVERSITY OF ROCHESTER · PI PHIPPS, RICHARD P. · 1994 to 2009
$2.7M
CD40 AND LUNG INFLAMMATION AND FIBROSISR01HL056002 · NHLBI · UNIVERSITY OF ROCHESTER · PI PHIPPS, RICHARD P. · 1997 to 2000
$229k
ACTIVATION OF PERIODONTAL FIBROBLASTS VIA CD40R29DE011785 · NIDCR · UNIVERSITY OF ROCHESTER · PI BLIEDEN, TIMOTHY M · 1996 to 2000
$117k
NHLBI NIH HHS HL56002NIDCR NIH HHS DE11390NIDCR NIH HHS DE11785
6 · The paper itself

Abstract

In this commentary, we have suggested that the fibroblast should be considered a sentinel cell. This concept is based on the fibroblast's ability to function both as a structural element and as a vital immunoregulatory cell. In some tissues, these capabilities may be ascribable to subsets of fibroblasts, rather than to some of the general fibroblast populations. The pioneering research of Xia et al, as well as that of others, highlights the need to explore the importance of fibroblasts as playing critical roles in disease. Emerging concepts regarding tissue-specific fibroblasts and fibroblast heterogeneity need to be considered in studies of their biosynthetic capabilities. Of special importance is the recent insight that the NF kappa B/RelB family of transcription proteins have apparently different regulatory roles in fibroblasts and hematopoietic cells. Therefore, with regard to therapeutic strategies targeting molecules such as RelB, caution should be exercised as their interruption may have very different consequences in macrophages compared with fibroblasts. For example, inhibition of RelB in macrophages may well prevent enhanced chemokine expression, whereas in fibroblasts, a critical governor for preventing chemokine expression would be lost. Overall, this could lead to exacerbation of inflammation rather than to an attenuation of the process.

Indexed as

AnimalsChemokinesFibroblastsHumansInflammationChemokines

Identifiers

PMID9250144
PMCPMC1858004
OpenAlexW113046667

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.